Press Room
Press Releases

July 29, 2010: INTRA-CELLULAR THERAPIES ANNOUNCES THE SUCCESSFUL COMPLETION OF A PHASE IB/II STUDY OF ITI-007 IN PATIENTS WITH SCHIZOPHRENIA - Read more.

December 21, 2009: INTRA-CELLULAR THERAPIES ANNOUNCES THE RESULTS OF A PHASE I PET STUDY FOR ITI-007 FOR THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHIATRIC DISORDERS - Read more.

March 10, 2009: INTRA-CELLULAR THERAPIES REPORTS POSITIVE FINAL RESULTS OF A PHASE II CLINICAL TRIAL WITH ITI-007 IN PATIENTS WITH SLEEP MAINTENANCE INSOMNIA - Read more.

January 13, 2009: INTRA-CELLULAR THERAPIES ANNOUNCES SUCCESSFUL OUTCOME OF A PHASE II CLINICAL TRIAL WITH ITI-007 IN PATIENTS WITH SLEEP MAINTENANCE INSOMNIA - Read more.

April 9, 2008: INTRA-CELLULAR THERAPIES ANNOUNCES THE DISCOVERY OF POTENT ANTIDEPRESSANT ACTIVITY IN ITI-007 - Read more.

February 15, 2008: INTRA-CELLULAR THERAPIES PRESENTS DATA ON ITS SCHIZOPHRENIA AND COGNITION IN SCHIZOPHRENIA PROGRAMS AT THE 14TH BIENNIAL WINTER WORKSHOP ON SCHIZOPHRENIA AND BIPOLAR DISORDERS - Read more.

December 20, 2007: INTRA-CELLULAR THERAPIES INITIATES PHASE 2 CLINICAL TRIAL FOR SLEEP MAINTENANCE INSOMNIA - Read more.

December 19, 2007: INTRA-CELLULAR THERAPIES PRESENTS PRECLINICAL DATA FROM SCHIZOPHRENIA AND SLEEP MAINTENANCE PROGRAMS - Read more.

September 18, 2007: INTRA-CELLULAR THERAPIES PROVIDES OVERVIEW OF ITS PROPRIETARY PORTFOLIO OF COMPOUNDS FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION (FSD) - Read more.

June 21, 2007: INTRA-CELLULAR THERAPIES INITIATES PHASE I CLINICAL PROGRAM FOR SCHIZOPHRENIA AND SLEEP MAINTENANCE DISORDERS- Read more.

June 1, 2005: INTRA-CELLULAR THERAPIES, INC. RECEIVES EXCLUSIVE LICENSE FOR CENTRAL NERVOUS SYSTEM COMPOUNDS FROM BRISTOL-MYERS SQUIBB COMPANY - Read more.